NASDAQ:CRVS - Corvus Pharmaceuticals Price Target & Analyst Ratings

$3.67
-0.13 (-3.42 %)
(As of 08/22/2019 04:00 PM ET)
Today's Range
$3.56
Now: $3.67
$3.81
50-Day Range
$3.56
MA: $4.82
$6.90
52-Week Range
$3.22
Now: $3.67
$11.23
Volume111,842 shs
Average Volume203,176 shs
Market Capitalization$107.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Analyst Ratings

Corvus Pharmaceuticals (NASDAQ:CRVS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Corvus Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.50, suggesting that the stock has a possible upside of 131.61%. The high price target for CRVS is $11.00 and the low price target for CRVS is $6.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.50$10.6667$14.3333$16.00
Price Target Upside: 131.61% upside173.50% upside252.17% upside95.12% upside

Corvus Pharmaceuticals (NASDAQ:CRVS) Consensus Price Target History

Corvus Pharmaceuticals (NASDAQ:CRVS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/29/2019Roth CapitalInitiated CoverageBuy ➝ Buy$5.00 ➝ $6.00MediumView Rating Details
3/13/2019WedbushLower Price TargetOutperform$19.00 ➝ $11.00HighView Rating Details
11/2/2018CowenReiterated RatingBuyLowView Rating Details
8/15/2018Credit Suisse GroupUpgradeNeutral ➝ Buy$11.00 ➝ $15.00LowView Rating Details
6/5/2018Jefferies Financial GroupInitiated CoverageBuy$17.00HighView Rating Details
(Data available from 8/22/2017 forward)
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel